BACKGROUND: Estimated glomerular filtration rate (eGFR) and albuminuria are central for diagnosis, staging, and risk evaluation in chronic kidney disease (CKD). Universal thresholds regardless of age, sex, and race are recommended, but relatively little is known about how these demographic factors alter the relationship of eGFR and albuminuria to cardiovascular outcomes. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 11,060 whites and blacks aged 52-75 years in the Atherosclerosis Risk in Communities (ARIC) Study with median follow-up of 11.2 years. PREDICTORS: eGFR by the CKD-EPI (CKD Epidemiology Collaboration) creatinine equation (reference, 95 mL/min/1.73 m(2)) and urinary albumin-creatinine ratio (ACR; reference, 5 mg/g). OUTCOMES: Cardiovascular events (coronary disease, stroke, and heart failure) and all-cause mortality. MEASUREMENTS: Adjusted HRs associated with eGFR and ACR in subgroups according to age, sex, and race. RESULTS: Cardiovascular risk significantly increased at eGFR <70 mL/min/1.73 m(2) in all subgroups according to age (<65 vs ≥65 years), sex, and race (P for interaction >0.2 for these subgroups; eg, at eGFR of 30 mL/min/1.73 m(2), the adjusted HR was 2.19 [95% CI, 1.10-4.35] at age 52-64 years vs 2.23 [95% CI, 1.33-3.72] at age 65-75 years). Results were similar for mortality. Log(ACR) was associated linearly with cardiovascular risk without threshold effects in all subgroups, with some quantitative interactions. HRs according to ACR tended to be lower in men versus women (eg, at ACR of 40 mg/g, 1.18 [95% CI, 0.98-1.41] vs 1.77 [95% CI, 1.45-2.15]) and in the older versus younger population (1.24 [95% CI, 1.04-1.49] vs 1.73 [95% CI, 1.42-2.12]; P for interaction <0.01 for sex and age). Less evident interactions were observed for mortality. LIMITATIONS: Single measurement of eGFR with creatinine and ACR and relatively narrow age range. CONCLUSIONS: The associations of eGFR and ACR with cardiovascular events were largely similar, with some quantitative interactions, in age, sex, and racial subgroups, generally supporting universal thresholds of GFR and ACR for CKD definition/staging.
BACKGROUND: Estimated glomerular filtration rate (eGFR) and albuminuria are central for diagnosis, staging, and risk evaluation in chronic kidney disease (CKD). Universal thresholds regardless of age, sex, and race are recommended, but relatively little is known about how these demographic factors alter the relationship of eGFR and albuminuria to cardiovascular outcomes. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 11,060 whites and blacks aged 52-75 years in the Atherosclerosis Risk in Communities (ARIC) Study with median follow-up of 11.2 years. PREDICTORS: eGFR by the CKD-EPI (CKD Epidemiology Collaboration) creatinine equation (reference, 95 mL/min/1.73 m(2)) and urinary albumin-creatinine ratio (ACR; reference, 5 mg/g). OUTCOMES: Cardiovascular events (coronary disease, stroke, and heart failure) and all-cause mortality. MEASUREMENTS: Adjusted HRs associated with eGFR and ACR in subgroups according to age, sex, and race. RESULTS: Cardiovascular risk significantly increased at eGFR <70 mL/min/1.73 m(2) in all subgroups according to age (<65 vs ≥65 years), sex, and race (P for interaction >0.2 for these subgroups; eg, at eGFR of 30 mL/min/1.73 m(2), the adjusted HR was 2.19 [95% CI, 1.10-4.35] at age 52-64 years vs 2.23 [95% CI, 1.33-3.72] at age 65-75 years). Results were similar for mortality. Log(ACR) was associated linearly with cardiovascular risk without threshold effects in all subgroups, with some quantitative interactions. HRs according to ACR tended to be lower in men versus women (eg, at ACR of 40 mg/g, 1.18 [95% CI, 0.98-1.41] vs 1.77 [95% CI, 1.45-2.15]) and in the older versus younger population (1.24 [95% CI, 1.04-1.49] vs 1.73 [95% CI, 1.42-2.12]; P for interaction <0.01 for sex and age). Less evident interactions were observed for mortality. LIMITATIONS: Single measurement of eGFR with creatinine and ACR and relatively narrow age range. CONCLUSIONS: The associations of eGFR and ACR with cardiovascular events were largely similar, with some quantitative interactions, in age, sex, and racial subgroups, generally supporting universal thresholds of GFR and ACR for CKD definition/staging.
Authors: Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort Journal: Lancet Date: 2010-05-17 Impact factor: 79.321
Authors: Ann M O'Hare; Susan M Hailpern; Meda E Pavkov; Nilka Rios-Burrows; Indra Gupta; Charles Maynard; Jeff Todd-Stenberg; Rudolph A Rodriguez; Brenda R Hemmelgarn; Rajiv Saran; Desmond E Williams Journal: Arch Intern Med Date: 2010-06-14
Authors: Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley Journal: N Engl J Med Date: 2009-03-19 Impact factor: 91.245
Authors: Peter A McCullough; Suying Li; Claudine T Jurkovitz; Lesley A Stevens; Changchun Wang; Allan J Collins; Shu-Cheng Chen; Keith C Norris; Samy I McFarlane; Bruce Johnson; Michael G Shlipak; Chamberlain I Obialo; Wendy Weinstock Brown; Joseph A Vassalotti; Adam T Whaley-Connell Journal: Am J Kidney Dis Date: 2008-04 Impact factor: 8.860
Authors: Peter A McCullough; Suying Li; Claudine T Jurkovitz; Leslie Stevens; Alan J Collins; Shu-Cheng Chen; Keith C Norris; Samy McFarlane; Bruce Johnson; Michael G Shlipak; Chamberlain I Obialo; Wendy W Brown; Joseph Vassalotti; Joseph Vassaloti; Adam T Whaley-Connell; Robert M Brenner; George L Bakris Journal: Am Heart J Date: 2008-06-04 Impact factor: 4.749
Authors: Neil T Raymond; Daniel Zehnder; Stephen C H Smith; Julie A Stinson; Hendrik Lehnert; Robert M Higgins Journal: Nephrol Dial Transplant Date: 2007-07-12 Impact factor: 5.992
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Lisandro D Colantonio; Usman Baber; Maciej Banach; Rikki M Tanner; David G Warnock; Orlando M Gutiérrez; Monika M Safford; Christoph Wanner; George Howard; Paul Muntner Journal: J Am Soc Nephrol Date: 2014-11-13 Impact factor: 10.121
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: David B Hanna; Shuo Xu; Michal L Melamed; Franklyn Gonzalez; Matthew A Allison; Martin S Bilsker; Barry E Hurwitz; Mayank M Kansal; Neil Schneiderman; Sanjiv J Shah; Robert C Kaplan; Carlos J Rodriguez; Jorge R Kizer Journal: Am J Cardiol Date: 2017-03-29 Impact factor: 2.778
Authors: Cristina M Arce; Jinnie J Rhee; Katharine L Cheung; Haley Hedlin; Kristopher Kapphahn; Nora Franceschini; Roberto S Kalil; Lisa W Martin; Lihong Qi; Nawar M Shara; Manisha Desai; Marcia L Stefanick; Wolfgang C Winkelmayer Journal: Am J Kidney Dis Date: 2015-09-01 Impact factor: 8.860
Authors: Pierre Delanaye; Kitty J Jager; Arend Bökenkamp; Anders Christensson; Laurence Dubourg; Bjørn Odvar Eriksen; François Gaillard; Giovanni Gambaro; Markus van der Giet; Richard J Glassock; Olafur S Indridason; Marco van Londen; Christophe Mariat; Toralf Melsom; Olivier Moranne; Gunnar Nordin; Runolfur Palsson; Hans Pottel; Andrew D Rule; Elke Schaeffner; Maarten W Taal; Christine White; Anders Grubb; Jan A J G van den Brand Journal: J Am Soc Nephrol Date: 2019-09-10 Impact factor: 10.121
Authors: Kunihiro Matsushita; Lucia Kwak; Shoshana H Ballew; Morgan E Grams; Elizabeth Selvin; Aaron R Folsom; Josef Coresh; Weihong Tang Journal: Atherosclerosis Date: 2018-09-01 Impact factor: 5.162